Delayed viral clearance despite high number of activated T cells during the acute phase in Argentinean patients with hantavirus pulmonary syndrome
Ayelén Aluminé Iglesias,
Natalia Períolo,
Carla María Bellomo,
Lorena Cecilia Lewis,
Camila Paula Olivera,
Constanza Rosario Anselmo,
Marina García,
Rocío María Coelho,
Daniel Oscar Alonso,
Bonnie Dighero-Kemp,
Heema Sharma,
Jens H. Kuhn,
Nicholas Di Paola,
Mariano Sanchez-Lockhart,
Gustavo Palacios,
Luis Pablo Schierloh,
Valeria Paula Martínez
Affiliations
Ayelén Aluminé Iglesias
Laboratorio Nacional de Referencia de Hantavirus, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán, Av. Vélez Sarsfield 563, Buenos Aires, Argentina
Natalia Períolo
Laboratorio Nacional de Referencia de Hantavirus, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán, Av. Vélez Sarsfield 563, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2290, Buenos Aires, Argentina
Carla María Bellomo
Laboratorio Nacional de Referencia de Hantavirus, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán, Av. Vélez Sarsfield 563, Buenos Aires, Argentina
Lorena Cecilia Lewis
Hospital Zonal de Esquel, Ministerio de Salud de Chubut, 25 De Mayo 150, Esquel, Argentina
Camila Paula Olivera
Hospital Zonal de Esquel, Ministerio de Salud de Chubut, 25 De Mayo 150, Esquel, Argentina
Constanza Rosario Anselmo
Hospital Zonal de Esquel, Ministerio de Salud de Chubut, 25 De Mayo 150, Esquel, Argentina
Marina García
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels allé 8, Floor 7, Stockholm 14152, Sweden
Rocío María Coelho
Laboratorio Nacional de Referencia de Hantavirus, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán, Av. Vélez Sarsfield 563, Buenos Aires, Argentina
Daniel Oscar Alonso
Laboratorio Nacional de Referencia de Hantavirus, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán, Av. Vélez Sarsfield 563, Buenos Aires, Argentina
Bonnie Dighero-Kemp
Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, B-8200 Research Plaza, Fort Detrick, Frederick, MD, USA
Heema Sharma
Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, B-8200 Research Plaza, Fort Detrick, Frederick, MD, USA
Jens H. Kuhn
Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, B-8200 Research Plaza, Fort Detrick, Frederick, MD, USA
Nicholas Di Paola
Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD, USA
Mariano Sanchez-Lockhart
Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD, USA
Gustavo Palacios
Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD, USA
Luis Pablo Schierloh
Instituto de Investigación y Desarrollo en Bioingenieria y Bioinformatica, Universidad Nacional de Entre Ríos, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2290, Buenos Aires, Argentina
Valeria Paula Martínez
Laboratorio Nacional de Referencia de Hantavirus, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán, Av. Vélez Sarsfield 563, Buenos Aires, Argentina; Corresponding author.
Summary: Background: The hallmarks of HPS are increase of vascular permeability and endothelial dysfunction. Although an exacerbated immune response is thought to be implicated in pathogenesis, clear evidence is still elusive. As orthohantaviruses are not cytopathic CD8+ T cells are believed to be the central players involved in pathogenesis. Methods: Serum and blood samples from Argentinean HPS patients were collected from 2014 to 2019. Routine white blood cell analyses, quantification and characterization of T-cell phenotypic profile, viral load, neutralizing antibody response and quantification of inflammatory mediators were performed. Findings: High numbers of activated CD4+ and CD8+ T cells were found in all HPS cases independently of disease severity. We found increased levels of some proinflammatory mediators during the acute phase of illness. Nonetheless, viral RNA remained high, showing a delay in clearance from blood up to late convalescence, when titers of neutralizing antibodies reached a high level. Interpretation: The high activated phenotypic profile of T cells seems to be unable to resolve infection during the acute and early convalescent phases, and it was not associated with the severity of the disease. Thus, at least part of the activated T cells could be induced by the dysregulated inflammatory response in an unspecific manner. Viral clearance seems to have been more related to high titers of neutralizing antibodies than to the T-cell response. Funding: This work was supported mainly by the Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Malbrán”. Further details of fundings sources is included in the appendix.